|
[1] Petersen PE, Baehni PC. Periodontal health and global public health. Periodontology 2000. 2012;60:7-14. [2] Organization WH. Oral health surveys basic methods, 4th edn. Geneva: World Health Organization. 1997. [3] Pilot T. The periodontal disease problem. A comparison between industrialised and developing countries. International dental journal. 1998;48:221-32. [4] Kingman A, Albandar JM. Methodological aspects of epidemiological studies of periodontal diseases. Periodontology 2000. 2002;29:11-30. [5] Petersen PE, Ogawa H. The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontology 2000. 2012;60:15-39. [6] M. C, RM. A, DE. B, M-H. L, CS. L. Comparing oral health care systems a second international collaborative study. Geneva: World Health Organization. 1997. [7] Organization. WH. The WHO global oral health data bank. Geneva: World Health Organization. 2007. [8] Ezzo PJ, Cutler CW. Microorganisms as risk indicators for periodontal disease. Periodontology 2000. 2003;32:24-35. [9] Tribble GD, Lamont RJ. Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontology 2000. 2010;52:68-83. [10] Jiang Y, Graves DT. Periodontal pathogens stimulate CC-chemokine production by mononuclear and bone-derived cells. Journal of periodontology. 1999;70:1472-8. [11] Kang IC, Kuramitsu HK. Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. FEMS immunology and medical microbiology. 2002;34:311-7. [12] Sandros J, Karlsson C, Lappin DF, Madianos PN, Kinane DF, Papapanou PN. Cytokine responses of oral epithelial cells to Porphyromonas gingivalis infection. Journal of dental research. 2000;79:1808-14. [13] Steffen MJ, Holt SC, Ebersole JL. Porphyromonas gingivalis induction of mediator and cytokine secretion by human gingival fibroblasts. Oral microbiology and immunology. 2000;15:172-80. [14] Gupta M, Chaturvedi R, Jain A. Role of monocyte chemoattractant protein-1 (MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease. Cytokine. 2013;61:892-7. [15] Erridge C, Bennett-Guerrero E, Poxton IR. Structure and function of lipopolysaccharides. Microbes and infection / Institut Pasteur. 2002;4:837-51. [16] Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885-91. [17] Fenton MJ, Golenbock DT. LPS-binding proteins and receptors. Journal of leukocyte biology. 1998;64:25-32. [18] Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 1984;312:724-9. [19] Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720-32. [20] Old LJ. Tumor necrosis factor (TNF). Science. 1985;230:630-2. [21] Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature. 1985;316:552-4. [22] Takeda K, Iwamoto S, Sugimoto H, Takuma T, Kawatani N, Noda M, et al. Identity of differentiation inducing factor and tumour necrosis factor. Nature. 1986;323:338-40. [23] Weber A, Wasiliew P, Kracht M. Interleukin-1 (IL-1) pathway. Science signaling. 2010;3:cm1. [24] Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood. 1995;86:1243-54. [25] Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. The Journal of clinical investigation. 1989;84:1045-9. [26] Ahuja SK, Ozcelik T, Milatovitch A, Francke U, Murphy PM. Molecular evolution of the human interleukin-8 receptor gene cluster. Nature genetics. 1992;2:31-6. [27] Ng N, Kaye EK, Garcia RI. Coffee Consumption and Periodontal Disease in Men. Journal of periodontology. 2013. [28] 咖啡的主要成分. http://zhwikipediaorg/zh-tw/%E5%92%96%E5%95%A#E59296E595A1E79A84E4B8BBE8A681E68890E58886. 2014. [29] Kim SR, Jung YR, Kim DH, An HJ, Kim MK, Kim ND, et al. Caffeic acid regulates LPS-induced NF-kappaB activation through NIK/IKK and c-Src/ERK signaling pathways in endothelial cells. Archives of pharmacal research. 2014;37:539-47. [30] Stauder M, Papetti A, Mascherpa D, Schito AM, Gazzani G, Pruzzo C, et al. Antiadhesion and antibiofilm activities of high molecular weight coffee components against Streptococcus mutans. Journal of agricultural and food chemistry. 2010;58:11662-6. [31] Genco CA, Cutler CW, Kapczynski D, Maloney K, Arnold RR. A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis. Infection and immunity. 1991;59:1255-63. [32] Cogo K, Montan MF, Bergamaschi Cde C, E DA, Rosalen PL, Groppo FC. In vitro evaluation of the effect of nicotine, cotinine, and caffeine on oral microorganisms. Canadian journal of microbiology. 2008;54:501-8. [33] Kim SR, Jung YR, Kim DH, An HJ, Kim MK, Kim ND, et al. Caffeic acid regulates LPS-induced NF-kappaB activation through NIK/IKK and c-Src/ERK signaling pathways in endothelial cells. Archives of pharmacal research. 2013. [34] Marquis A, Genovese S, Epifano F, Grenier D. The plant coumarins auraptene and lacinartin as potential multifunctional therapeutic agents for treating periodontal disease. BMC complementary and alternative medicine. 2012;12:80. [35] Feldman M, Grenier D. Cranberry proanthocyanidins act in synergy with licochalcone A to reduce Porphyromonas gingivalis growth and virulence properties, and to suppress cytokine secretion by macrophages. Journal of applied microbiology. 2012;113:438-47. [36] Tipton DA, Cho S, Zacharia N, Dabbous MK. Inhibition of interleukin-17-stimulated interleukin-6 and -8 production by cranberry components in human gingival fibroblasts and epithelial cells. Journal of periodontal research. 2013;48:638-46. [37] Tang X, Pan Y, Zhao Y. Vitamin D inhibits the expression of interleukin-8 in human periodontal ligament cells stimulated with Porphyromonas gingivalis. Archives of oral biology. 2013;58:397-407.
|